Recurrent NSCLC
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451) | Lyell Immunopharma, Inc. | 2022-03-29 |
| Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC (NCT04846452) | The First Affiliated Hospital with Nanjing Medical University | 2021-06-01 |
| Phase 2 Study of Dacomitinib in NSCLC (NCT04027647) | National Cancer Centre, Singapore | 2019-09-11 |
| Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) (NCT00813332) | Simcere Pharmaceutical Co., Ltd | 2008-10-01 |
Track Recurrent NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.